340 related articles for article (PubMed ID: 24439980)
1. The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure.
Ahmad T; Fiuzat M; Mark DB; Neely B; Neely M; Kraus WE; Kitzman DW; Whellan DJ; Donahue M; Zannad F; Piña IL; Adams K; O'Connor CM; Felker GM
Am Heart J; 2014 Feb; 167(2):193-202.e1. PubMed ID: 24439980
[TBL] [Abstract][Full Text] [Related]
2. Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study).
Seliger SL; de Lemos J; Neeland IJ; Christenson R; Gottdiener J; Drazner MH; Berry J; Sorkin J; deFilippi C
JACC Heart Fail; 2015 Jun; 3(6):445-455. PubMed ID: 25982111
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with baseline and serial changes in circulating NT-proBNP and high-sensitivity cardiac troponin T in a population-based cohort (Dallas Heart Study).
Puleo CW; Ayers CR; Garg S; Neeland IJ; Lewis AA; Pandey A; Drazner MH; de Lemos JA
Biomark Med; 2021 Nov; 15(16):1487-1498. PubMed ID: 34663078
[No Abstract] [Full Text] [Related]
4. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in acute heart failure: Data from the ACE 2 study.
Berge K; Lyngbakken MN; Myhre PL; Brynildsen J; Røysland R; Strand H; Christensen G; Høiseth AD; Omland T; Røsjø H
Clin Biochem; 2021 Feb; 88():30-36. PubMed ID: 33245872
[TBL] [Abstract][Full Text] [Related]
5. Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk.
Glick D; deFilippi CR; Christenson R; Gottdiener JS; Seliger SL
JACC Heart Fail; 2013 Aug; 1(4):353-360. PubMed ID: 24621939
[TBL] [Abstract][Full Text] [Related]
6. Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
Felker GM; Anstrom KJ; Adams KF; Ezekowitz JA; Fiuzat M; Houston-Miller N; Januzzi JL; Mark DB; Piña IL; Passmore G; Whellan DJ; Yang H; Cooper LS; Leifer ES; Desvigne-Nickens P; O'Connor CM
JAMA; 2017 Aug; 318(8):713-720. PubMed ID: 28829876
[TBL] [Abstract][Full Text] [Related]
7. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.
Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM
Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.
Neeland IJ; Drazner MH; Berry JD; Ayers CR; deFilippi C; Seliger SL; Nambi V; McGuire DK; Omland T; de Lemos JA
J Am Coll Cardiol; 2013 Jan; 61(2):187-95. PubMed ID: 23219305
[TBL] [Abstract][Full Text] [Related]
9. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure.
Pastormerlo LE; Agazio A; Benelli E; Gabutti A; Poletti R; Prontera C; Clerico A; Emdin M; Passino C
Am J Cardiol; 2015 Aug; 116(4):567-72. PubMed ID: 26089013
[TBL] [Abstract][Full Text] [Related]
11. Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.
Rengo G; Pagano G; Parisi V; Femminella GD; de Lucia C; Liccardo D; Cannavo A; Zincarelli C; Komici K; Paolillo S; Fusco F; Koch WJ; Perrone Filardi P; Ferrara N; Leosco D
Int J Cardiol; 2014 Feb; 171(3):384-9. PubMed ID: 24388546
[TBL] [Abstract][Full Text] [Related]
12. Comparison of prognostic values of high-sensitivity cardiac troponin T and N-terminal prohormone brain natriuretic peptide to assess mortality in elderly inpatients.
Chen JR; Wang Q; Wu W; Zhang SJ
Clin Interv Aging; 2019; 14():81-90. PubMed ID: 30643397
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved.
Januzzi JL; Butler J; Zannad F; Filippatos G; Ferreira JP; Pocock SJ; Sattar N; Verma S; Vedin O; Iwata T; Brueckmann M; Packer M; Anker SD;
JACC Heart Fail; 2022 Jul; 10(7):512-524. PubMed ID: 35670067
[TBL] [Abstract][Full Text] [Related]
14. Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study.
Welsh P; Kou L; Yu C; Anand I; van Veldhuisen DJ; Maggioni AP; Desai AS; Solomon SD; Pfeffer MA; Cheng S; Gullestad L; Aukrust P; Ueland T; Swedberg K; Young JB; Kattan MW; Sattar N; McMurray JJV
Eur J Heart Fail; 2018 Feb; 20(2):268-277. PubMed ID: 28960777
[TBL] [Abstract][Full Text] [Related]
15. Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction.
Murphy SP; Prescott MF; Maisel AS; Butler J; Piña IL; Felker GM; Ward JH; Williamson KM; Camacho A; Kandanelly RR; Solomon SD; Januzzi JL
Circ Heart Fail; 2021 Jun; 14(6):e008410. PubMed ID: 33998243
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T.
Aimo A; Januzzi JL; Vergaro G; Richards AM; Lam CSP; Latini R; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; de Boer RA; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Passino C; Emdin M
Eur J Heart Fail; 2020 Nov; 22(11):2078-2088. PubMed ID: 31919929
[TBL] [Abstract][Full Text] [Related]
17. Identifying biomarker patterns and predictors of inflammation and myocardial stress.
Masterson Creber RM; Lee CS; Margulies K; Riegel B
J Card Fail; 2015 Jun; 21(6):439-45. PubMed ID: 25727486
[TBL] [Abstract][Full Text] [Related]
18. Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure: Insights From the HF-ACTION Study.
Sharma A; Stevens SR; Lucas J; Fiuzat M; Adams KF; Whellan DJ; Donahue MP; Kitzman DW; Piña IL; Zannad F; Kraus WE; O'Connor CM; Felker GM
JACC Heart Fail; 2017 Oct; 5(10):724-734. PubMed ID: 28958347
[TBL] [Abstract][Full Text] [Related]
19. N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study.
Felker GM; Whellan D; Kraus WE; Clare R; Zannad F; Donahue M; Adams K; McKelvie R; Piña IL; O'Connor CM;
Am Heart J; 2009 Oct; 158(4 Suppl):S37-44. PubMed ID: 19782787
[TBL] [Abstract][Full Text] [Related]
20. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
Clin Chem; 2010 Nov; 56(11):1718-24. PubMed ID: 20844063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
